Danaher Corporation - Asset Resilience Ratio
Danaher Corporation (DHR) has an Asset Resilience Ratio of 1.91% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Danaher Corporation carry for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2009–2024)
This chart shows how Danaher Corporation's Asset Resilience Ratio has changed over time. See Danaher Corporation net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Danaher Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Danaher Corporation (DHR) market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $1.53 Billion | 1.91% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $1.53 Billion | 1.91% |
Asset Resilience Insights
- Limited Liquidity: Danaher Corporation maintains only 1.91% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Danaher Corporation Industry Peers by Asset Resilience Ratio
Compare Danaher Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Eurofins-Cerep SA
PA:ALECR |
Diagnostics & Research | 6.56% |
|
Inoviq Ltd
AU:IIQ |
Diagnostics & Research | 56.29% |
|
Bcal Diagnostics Ltd
AU:BDX |
Diagnostics & Research | 0.00% |
|
Imagion Biosystems Ltd
AU:IBX |
Diagnostics & Research | 150.16% |
|
Integral Diagnostics Ltd
AU:IDX |
Diagnostics & Research | 0.03% |
|
Australian Clinical Labs Ltd
AU:ACL |
Diagnostics & Research | 4.11% |
|
Monash Ivf Group Ltd
AU:MVF |
Diagnostics & Research | 1.60% |
Annual Asset Resilience Ratio for Danaher Corporation (2009–2024)
The table below shows the annual Asset Resilience Ratio data for Danaher Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 2.68% | $2.08 Billion | $77.54 Billion | -4.26pp |
| 2023-12-31 | 6.94% | $5.86 Billion | $84.49 Billion | -0.17pp |
| 2022-12-31 | 7.11% | $6.00 Billion | $84.35 Billion | +4.00pp |
| 2021-12-31 | 3.11% | $2.59 Billion | $83.18 Billion | -4.82pp |
| 2020-12-31 | 7.92% | $6.04 Billion | $76.16 Billion | -24.15pp |
| 2019-12-31 | 32.07% | $19.91 Billion | $62.08 Billion | +30.43pp |
| 2018-12-31 | 1.65% | $787.80 Million | $47.83 Billion | +0.30pp |
| 2017-12-31 | 1.35% | $630.30 Million | $46.65 Billion | -0.78pp |
| 2016-12-31 | 2.13% | $963.70 Million | $45.30 Billion | -- |
| 2015-12-31 | 0.00% | $0.00 | $48.22 Billion | -- |
| 2014-12-31 | 0.00% | $0.00 | $36.99 Billion | -- |
| 2013-12-31 | 0.00% | $0.00 | $34.67 Billion | -- |
| 2012-12-31 | 0.00% | $0.00 | $32.94 Billion | -- |
| 2011-12-31 | 0.00% | $0.00 | $29.95 Billion | -- |
| 2010-12-31 | 0.00% | $0.00 | $22.22 Billion | -- |
| 2009-12-31 | 0.00% | $0.00 | $19.60 Billion | -- |
About Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the deve… Read more